Stock Events

Stock Events

Abpro Bio. 

₩1,278
2
-₩34-2.59% Today

Statistics

Day High
1,328
Day Low
1,264
52W High
2,415
52W Low
140
Volume
139,940
Avg. Volume
-
Mkt Cap
363.83B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 16
₩700
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31DecExpected
Q4 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q3 2018
-92.22
-59.72
-27.22
5.28
Expected EPS
N/A
Actual EPS
-92.2183

Financials

-49.36%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
63.33BRevenue
-31.26BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 195990.KQ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.46B
Regeneron Pharmaceuticals is a leading biotech company focusing on immunology and inflammatory diseases, directly competing with Abpro Bio's therapeutic antibody development.
AMGEN
AMGN
Mkt Cap185.74B
Amgen is a biotechnology firm specializing in human therapeutics, with a strong focus on innovations in human antibodies, similar to Abpro Bio's core activities.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.45B
Vertex Pharmaceuticals engages in developing and commercializing therapies for treating cystic fibrosis and other severe diseases, overlapping with Abpro Bio's disease target areas.
Biogen
BIIB
Mkt Cap27.06B
Biogen focuses on neuroscience, developing therapies for diseases with mechanisms similar to those targeted by Abpro Bio's antibody therapies.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences is known for its work in antiviral drugs, including for HIV/AIDS, liver diseases, and other areas that might compete with Abpro Bio's therapeutic solutions.
Incyte
INCY
Mkt Cap18.84B
Incyte Corporation works on novel therapeutics for oncology and inflammation, competing in the same biopharmaceutical niche as Abpro Bio.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.28B
BioMarin Pharmaceutical targets rare genetic diseases with therapeutic enzymes, a market also addressed by Abpro Bio's research and development efforts.
Exelixis
EXEL
Mkt Cap11.42B
Exelixis is a biotechnology company that develops small molecule therapies for cancer, which could be seen as alternative treatments to Abpro Bio's antibody-based therapies.

About

Abpro Bio Co., Ltd. manufactures and sells machine tools in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. The company was founded in 1991 and is headquartered in Daegu, South Korea.
Show more...
CEO
Mr. Lee Jae-yong
Employees
44
Country
South Korea
ISIN
KR7195990007

Listings

KQ
KR
195990.KQ

0 Comments

Share your thoughts

FAQ

What is Abpro Bio. stock price today?▼
The current price of 195990.KQ is ₩1,278 KRW — it has decreased by -2.59% in the past 24 hours. Watch Abpro Bio. stock price performance more closely on the chart.
What is Abpro Bio. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abpro Bio. stocks are traded under the ticker 195990.KQ.
Is Abpro Bio. stock price growing?▼
195990.KQ stock has fallen by -7.86% compared to the previous week, the month change is a -6.92% fall, over the last year Abpro Bio. has showed a +299.38% increase.
What is Abpro Bio. market cap?▼
Today Abpro Bio. has the market capitalization of 363.83B
What were Abpro Bio. earnings last quarter?▼
195990.KQ earnings for the last quarter are -92.22 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is Abpro Bio. revenue for the last year?▼
Abpro Bio. revenue for the last year amounts to 63.33B KRW.
What is Abpro Bio. net income for the last year?▼
195990.KQ net income for the last year is -31.26B KRW.
Does Abpro Bio. pay dividends?▼
Yes, 195990.KQ dividends are paid annual. The last dividend per share was 700 KRW. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Abpro Bio. have?▼
As of April 27, 2026, the company has 44 employees.
In which sector is Abpro Bio. located?▼
Abpro Bio. operates in the Manufacturing sector.
When did Abpro Bio. complete a stock split?▼
The last stock split for Abpro Bio. was on September 11, 2017 with a ratio of 1:5.
Where is Abpro Bio. headquartered?▼
Abpro Bio. is headquartered in Daegu, South Korea.